Sort
23,748 grants matching “melanoma”
Promoting tumor cell apoptosis by death ligands
$473,179Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
VEGFs in tumor lymphatic metastasis
$473,057Laura E Benjamin · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA
Allosteric mechanisms driving paradoxical activation of RAF kinases
$473,037Nicholas Mark Levinson · University Of Minnesota · R01 · FY2025 · CA
EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma
$472,957Richard Lee Nuccitelli · Bioelectromed Corporation · R43 · FY2010 · CA
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$472,759Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2023 · EB
Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity
$472,728Jerry D Glickson · University Of Pennsylvania · R01 · FY2012 · CA
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$472,585Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$472,585Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
Targeting the MAP and PI3 Kinase Pathways in Melanoma
$472,518Meenhard Herlyn · Wistar Institute · P01 · FY2009 · CA
SOUTHWEST ONCOLOGY GROUP
$472,474University Of Rochester · U10 · FY2001 · CA
Mechanical control of cell growth and differentiation
$472,344Paul A Janmey · University Of Pennsylvania · R01 · FY2011 · GM
THE THERAPEUTIC EFFECTS OF ULTRASOUND-MEDIATED IMMUNE RESPONSES IN MELANOMA
$472,294Rector & Visitors Of The University Of Virginia · · FY2015 · Department of the Army
Credentialing murine models for glioblastoma preclinical drug development
$472,269Christopher Ryan Miller · University Of Alabama At Birmingham · R01 · FY2019 · CA
Wounding Therapy and Photocarcinogenesis
$472,255Jeffrey B. Travers · Wright State University · R01 · FY2022 · AG
DEVELOPMENTAL ORIGINS AND HOMEOSTATIC MECHANISMS UNDERLYING ADULT PHENOTYPES
$472,240David M Parichy · University Of Virginia · R35 · FY2017 · GM
Structural and functional characterization of T and NK cell receptors
$472,217Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Developmental Funds
$472,141Dario C. Altieri · Wistar Institute · P30 · FY2016 · CA
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$472,110Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2022 · EB
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$472,052David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
$471,895Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Effects of autoantibodies on synaptic transmission in the retina
$471,865Catherine W Morgans · Oregon Health & Science University · R01 · FY2016 · EY
Effects of autoantibodies on synaptic transmission in the retina
$471,865Catherine W Morgans · Oregon Health & Science University · R01 · FY2013 · EY
B7-H1/PD-1 modulation in cancer therapy
$471,842Drew M. Pardoll · Johns Hopkins University · R01 · FY2012 · CA
NCI National Clinical Trials Network â Network Lead Academic Participating Site
$471,635Lawrence E Flaherty · Wayne State University · UG1 · FY2023 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$471,626James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA